Compare KraneShares Electric Vehicles and Future Mobility (KARS) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
KraneShares Electric Vehicles and Future Mobility vs Summit Therapeutics Inc — how do they compare? KraneShares Electric Vehicles and Future Mobility trades at $30.53, while Summit Therapeutics Inc trades at $15.35 (market cap $12.06B). The key difference: KraneShares Electric Vehicles and Future Mobility is trading nearer its 52-week high, Summit Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| KARS | SMMT | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $38.01 | $26.98 |
52-Week Low | $25.59 | $12.55 |
Market Cap | — | $12.06B |
Enterprise Value | — | $11.39B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About KraneShares Electric Vehicles and Future Mobility
KARS invests in the global electric vehicle ecosystem and future mobility. It tracks the Bloomberg Electric Vehicles Index, providing exposure to EV manufacturers, battery technology, and lithium miners like Tesla, BYD, and Albemarle.
Read more on KARS →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
